Review Article Volume 22 Issue 11 - 2026

Pathogenesis of Acute Pancreatitis

Andrija Badanjak1 and Gordana Blagojević Zagorac2,3*

1Health Centre Popovača, Croatia
2Medical Faculty, University of Rijeka, Rijeka, Croatia
3University North, Varaždin, Croatia

*Corresponding Author: Gordana Blagojević Zagorac, Professor, Department of Physiology, Immunology and Pathophisiology, Medical Faculty, University of Rijeka, Croatia.
Received: October 13, 2026; Published: October 30, 2026



Acute pancreatitis is an acute inflammation of the exocrine pancreas and is considered a common and severe disease. The most common etiological factors are excessive alcohol consumption and gallstones. The disease has a sudden onset and may rapidly prog- ress to a severe and potentially life-threatening condition. Treatment of acute pancreatitis is primarily conservative and largely based on supportive care and to date, no specific targeted pharmacological therapy for acute pancreatitis has been developed. A better understanding of the pathogenesis of acute pancreatitis may facilitate the identification of key molecular and cellular mechanisms involved in pancreatic inflammation and contribute to the discovery of novel, more specific therapeutic approaches targeting factors that play an important role. This review summarizes current knowledge of the pathogenesis of acute pancreatitis.

Keywords:

Acute Pancreatitis (AP); Pathogenesis; Pancreatic Inflammation; Systemic Inflammatory Response Syndrome (SIRS).

  1. Mihoc T., et al. “Pancreatic morphology, immunology, and the pathogenesis of acute pancreatitis”. Biomedicines11 (2024): 2627. 
  2. Foster BR., et al. “Revised Atlanta Classification for Acute Pancreatitis: A Pictorial Essay”. RadioGraphics3 (2016): 675-687. 
  3. Tenner S., et al. “American College of Gastroenterology Guidelines: Management of Acute Pancreatitis”. The American Journal of Gastroenterology3 (2024): 419-437. 
  4. van den Berg FF and Boermeester MA. “Update on the management of acute pancreatitis”. Current Opinion in Critical Care2 (2023): 145-151. 
  5. Zheng Z., et al. “A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management”. Annals of Translational Medicine1 (2021): 69. 
  6. Petersen OH. “The 2022 George E Palade Medal Lecture: Toxic Ca²⁺ signals in acinar, stellate and endogenous immune cells are important drivers of acute pancreatitis”. Pancreatology1 (2023): 1-8. 
  7. Zaman S and Gorelick F. “Acute pancreatitis: pathogenesis and emerging therapies”. Journal of Pancreatology1 (2024): 10-20. 
  8. Chen F., et al. “Mitochondrial dysfunction in pancreatic acinar cells: mechanisms and therapeutic strategies in acute pancreatitis”. Frontiers in Immunology 15 (2024): 1503087. 
  9. Geisz-Fremy A. “Pathologically relevant trypsinogen activation in pancreatitis”. American Journal of Physiology-Gastrointestinal and Liver Physiology2 (2026): G87-G97. 
  10. Modenbach JM., et al. “Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis”. Nature Communications1 (2025): 1702. 
  11. Sah RP., et al. “New insights into the pathogenesis of pancreatitis”. Current Opinion in Gastroenterology5 (2013): 523-530. 
  12. Luo M., et al. “Signaling pathways involved in acute pancreatitis”. Journal of Inflammation Research 18 (2025): 2287-2303. 
  13. Zhang D., et al. “Mitochondrial DNA leakage promotes persistent pancreatic acinar cell injury in acute pancreatitis via the cGAS-STING-NF-κB pathway”. Inflammation3 (2025): 1420-1437. 
  14. Gukovskaya AS., et al. “Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis”. Gastroenterology5 (2017): 1212-1226. 
  15. Ding WX., et al. “Recent insights about autophagy in pancreatitis”. eGastroenterology2 (2024): e100057. 
  16. Hu Q., et al. “Acute pancreatitis: mechanisms and therapeutic approaches”. Signal Transduction and Targeted Therapy1 (2026): 15. 
  17. Li H., et al. “Targeting endoplasmic reticulum stress as an effective treatment for alcoholic pancreatitis”. Biomedicines1 (2022): 108. 
  18. Kubisch CH., et al. “Early activation of endoplasmic reticulum stress is associated with arginine-induced acute pancreatitis”. American Journal of Physiology-Gastrointestinal and Liver Physiology2 (2006): G238-G245. 
  19. Bravo R., et al. “Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration”. International Review of Cell and Molecular Biology 301 (2013): 215-290. 
  20. Zhang X., et al. “Endoplasmic reticulum stress in acute pancreatitis: exploring the molecular mechanisms and therapeutic targets”. Cell Stress and Chaperones3 (2025): 119-129. 
  21. Guo XY., et al. “Exosomes and pancreatic diseases: status, challenges, and hopes”. International Journal of Biological Sciences9 (2019): 1846-1860. 
  22. Ruan K., et al. “Exosomes in acute pancreatitis: pathways to cellular death regulation and clinical application potential”. International Immunopharmacology 153 (2025): 114491. 
  23. Su XJ., et al. “Exosomes derived from cerulein-stimulated pancreatic acinar cells mediate peritoneal macrophage M1 polarization and pyroptosis via an miR-24-3p/MARCH3/NLRP3 axis in acute pancreatitis”. Pancreas8 (2024): e641-e651. 
  24. Hong Y., et al. “Stem cell-derived extracellular vesicles for acute pancreatitis: a systematic review and meta-analysis of preclinical studies”. Stem Cell Reviews and Reports3 (2025): 767-778. 

Andrija Badanjak and Gordana Blagojević Zagorac. “Pathogenesis of Acute Pancreatitis”. EC Microbiology 22.11 (2026): 01-07.